微泡
生物相容性
肿瘤微环境
外体
黑色素瘤
药物输送
化学
癌症研究
免疫系统
免疫疗法
药品
纳米医学
细胞
受体
炎症
内体
介孔二氧化硅
全身给药
树突状细胞
自愈水凝胶
细胞生物学
透明质酸
癌症免疫疗法
毒品携带者
靶向给药
细胞培养
免疫原性细胞死亡
作者
Yunan Yuan,Yijun Wu,Jiaxuan Yang,Fujiang Li,Ruonan Huang,Qian Cheng,Yan Rong,Chaoliang He
摘要
The therapeutic efficacy of melanoma immunochemotherapy is severely limited by insufficient intratumoral drug retention, systemic toxicity, and immunosuppressive tumor microenvironment (TME). Thus, we developed a single-dose injectable localized chemo-immunotherapy platform that enables sustained tumor-restricted delivery and synergistic immune remodeling. This hybrid system integrates doxorubicin-loaded tumor-derived exosome-coated hollow mesoporous silica nanoparticles (DeH) with a mannose-modified β-cyclodextrin-polyethyleneimine carrier co-delivering dual Toll-like receptor agonists (RC-MCP) within a thermoresponsive polypeptide hydrogel (mPEG-b-PELG). The biomimetic exosome coating provides an exosome-sheathed nanostructure and amplifies doxorubicin-induced immunogenic cell death. Mannose-mediated targeting facilitates preferential uptake by antigen-presenting cells and enhances endosomal Toll-like receptor signaling, leading to robust dendritic cell maturation. Following intratumoral injection, the hydrogel undergoes in situ sol-gel transition to form a stable drug depot, enabling sustained and coordinated release while minimizing systemic exposure. As a result, a single intratumoral administration elicits potent antitumor immune responses, significantly suppresses tumor growth, alleviates TME immunosuppression, and exhibits favorable biocompatibility in murine melanoma model. Collectively, this work presents a rationally designed single-dose localized chemo-immunotherapy strategy for melanoma treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI